Patients with severe asthma which is not controlled with standard treatment – leaving them at risk of severe asthma attacks – could benefit from using a single inhaler combining three, instead of two therapies, according to two phase 3 randomised controlled trials with over 2,500 patients across 17 countries, published in The Lancet and simultaneously presented at the European Respiratory Society (ERS) Conference 2019
References:
Join the Fight Against Chronic Urticaria: Participate in Our Clinical Trial! Do you suffer from a rash that is caused by exposure to cold weather, ice cubes or cold water? Chronic urticaria induced by environmental stimuli like the cold is a rare condition that can be...
[ hundred_percent="yes" overflow="visible"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" last="yes" spacing="yes" center_content="no" hide_on_mobile="no" background_color="" background_image="" background_repeat="no-repeat"...
0 Comments